%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-07-07T10:44:52+03:00
2013-07-07T10:44:51+03:00
2013-07-07T10:44:52+03:00
Adobe Acrobat 10.0
application/pdf
bs-9910R-Cy7.htm
uuid:178c13a2-21ca-480d-a554-45d87aa0ccac
uuid:52fed76b-55d0-4a90-b911-1a56e46fe1c6
Acrobat Web Capture 10.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
8 0 obj
<>
endobj
15 0 obj
<>>>
endobj
16 0 obj
<>
endobj
17 0 obj
<>
endobj
19 0 obj
[18 0 R 18 0 R 18 0 R]
endobj
20 0 obj
[18 0 R 18 0 R 18 0 R]
endobj
18 0 obj
<><><>]/P 16 0 R/Pg 13 0 R/S/Article>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/StructParents 0/Type/Page>>
endobj
21 0 obj
[35 0 R]
endobj
22 0 obj
<>stream
BT
/Artifact <>BDC
/TT0 1 Tf
8.2092 0 0 8.2092 5 779 Tm
(bs-9910R-Cy7)Tj
EMC
/Artifact <>BDC
0 -94.284 TD
(file:///F|/mimi/bs-9910R-Cy7.htm)Tj
([07/07/13 10:44:52])Tj
EMC
ET
1 g
10 765.939 591.75 -729.939 re
f
/Article <>BDC
BT
0.2 g
/TT1 1 Tf
6.841 0 0 6.841 21.6298 715.9994 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw T*
[(800.501.7654)-34( )1([DOMESTIC])]TJ
T*
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
451.247 678.374 145.714 82.092 re
W n
q
/GS0 gs
145.7141571 0 0 -82.0924835 451.2471008 760.4661713 cm
/Im0 Do
Q
Q
BT
0 g
/TT2 1 Tf
0 Tw 9.5775 0 0 9.5775 21.6298 662.6393 Tm
[(bs)-67(-)-69(9910R)-12(-)-69(Cy7)]TJ
/TT1 1 Tf
-0.04 Tw 7.5251 0 0 7.5251 29.1549 614.752 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT2 1 Tf
0 Tw 0 -2.091 TD
(Background:)Tj
/TT1 1 Tf
-0.04 Tw 0 -1.455 TD
[(Phosphatidylinositol)-39(-)-1(glycan)-85(-)-1(specific)-50( phospholipase)-11( D)-49( \(GPI)-26(-)-1(PLD\))-72( is)-52( a)-20( high)-11(-)-1(density)-38( lipoprotein)-70(-)-1(associated)-48( protein)]TJ
0 -1.455 TD
[(found)-15( on)-81( chromosome)-67( 6p22)-82( that)-67( specifically)-23( hydrolyzes)-72( the)-37( inositol)-71( phosphate)-40( linkage)-64( in)-31( proteins)-87( anchored)-7( by)]TJ
T*
[(phosphatidylinositol)-37(-)-1(glycans)-3( \(PI)-57(-)-1(Gs\).)-19( GPI)-45(-)-1(PLD is)-52( found)-15( in)-31( serum,)-58( liver,)-37( cerebrospinal)-40( fluid)-22( and in)-31( milk.)-83( The)]TJ
0 -1.455 TD
[(majority)-25( of)-48( plasma)-64( GPI)-45(-)-1(PLD appears)-57( to)-32( be)-12( specifically)-23( associated)-48( with)-46( a)-20( small,)-64( discrete)-19( and minor)-15( fraction)-36( of)]TJ
T*
[(lipoproteins)-79( containing)-88( apoA)-52(-)-1(I)-81( and apoA)-52(-)-1(IV. Serum)-68( GPI)-45(-)-1(PLD activity)-74( is)-52( reduced)-8( over)-73( 75%)-22( in)-31( systemic)]TJ
0 -1.455 TD
[(inflammatory)-19( response)-42( syndrome)-40( and the)-37( downregulation)-7( of)-48( GPI)-45(-)-1(PLD could)-20( play)-13( an)-8( important)-88( role)-69( in)-31( the)-36( control)]TJ
T*
[(of)-48( proinflammatory)-18( responses.)]TJ
/TT2 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT1 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT2 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT1 1 Tf
-0.04 Tw 0 -1.455 TD
[(Prepared)-46( as)-29( lyophilized)-45( powder)-87( or)-6( liquid)-13( and shipped)-37( on)-81( ice.)-26( Store)-44( at)-50( -)-1(20\260C)-18( for)-52( one)-9( year.)-61( Protect)-73( from)-30( light.)]TJ
/TT2 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT1 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( it)-73( is)-52( ready)-83( to)-32( use,)-76( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-37( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-37( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-37( package.)]TJ
/TT2 1 Tf
0 Tw 54.182 28.364 Td
(Size:)Tj
/TT1 1 Tf
-0.04 Tw 3 -0.091 Td
[(100ul)-29( or)-6( 100ug)-69( lyophilized)]TJ
/TT2 1 Tf
0 Tw -3 -2.818 Td
(Concentration:)Tj
/TT1 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT2 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT1 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT2 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 g
/TT1 1 Tf
6.841 0 0 6.841 496.3979 577.8104 Tm
(Human,Mouse,Rat,Horse,)Tj
0 g
/TT2 1 Tf
7.5251 0 0 7.5251 436.8809 563.4442 Tm
(Application:)Tj
ET
q
10 36 592 730 re
W n
q 1 0 0 1 447.1425 545.3154 cm
0 0 m
0 1.368 -2.052 1.368 -2.052 0 c
-2.052 -1.368 0 -1.368 0 0 c
f
Q
Q
BT
/TT1 1 Tf
7.5251 0 0 7.5251 453.9835 543.6052 Tm
[(IF\(1:50)-4(-)-1(200\))]TJ
ET
q
10 36 592 730 re
W n
q 1 0 0 1 447.1425 534.3698 cm
0 0 m
0 1.368 -2.052 1.368 -2.052 0 c
-2.052 -1.368 0 -1.368 0 0 c
f
Q
Q
BT
/TT1 1 Tf
-0.04 Tw 7.5251 0 0 7.5251 453.9835 532.6595 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)]TJ
T*
[(Optimal)-36( working)-62( dilutions)-48( must)-4( be)]TJ
0 -1.455 TD
[(determined)-86( by)-40( the)-36( end)-90( user.)]TJ
/TT2 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT1 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT2 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 g
/TT1 1 Tf
6.841 0 0 6.841 481.3477 466.9855 Tm
(IgG)Tj
0 g
/TT2 1 Tf
-0.02 Tw 7.5251 0 0 7.5251 436.8809 452.6194 Tm
[(Molecular)-1( Weight:)]TJ
0.2 g
/TT1 1 Tf
0 Tw 6.841 0 0 6.841 518.2893 452.6194 Tm
(90kDa)Tj
0 g
/TT2 1 Tf
7.5251 0 0 7.5251 436.8809 438.2532 Tm
(Preservatives:)Tj
0.2 g
/TT1 1 Tf
-0.012 Tw 6.841 0 0 6.841 436.8809 427.9916 Tm
[(10ug/uL)-59( )1(BSA)-54( )1(and)-64( )1(0.1%)-28( )1(NaN3.)]TJ
0 g
0.021 Tw 6.1569 0 0 6.1569 436.8809 399.9434 Tm
[(For)-20( )1(research)-16( )1(use)-25( )1(only.)-91( )1(CAUTION:)-13( )1(Not)-12( )1(for)-1( )1(human)-72( )1(or)]TJ
0 -1.333 TD
[(animal)-94( )1(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
15.473 653.062 581.488 0.684 re
W n
q
/GS0 gs
581.4884033 0 0 -0.6840973 15.4728394 653.7459412 cm
/Im1 Do
Q
Q
q
10 36 592 730 re
W n
0.302 0.306 0.333 rg
q 1 0 0 1 19.5775 638.0115 cm
0 0 m
0 1.824 -2.736 1.824 -2.736 0 c
-2.736 -1.824 0 -1.824 0 0 c
f
Q
Q
BT
0.302 0.306 0.333 rg
/TT2 1 Tf
-0.007 Tw 9.5775 0 0 9.5775 29.1549 635.2751 Tm
[(Rabbit)-50( Anti)-28(-)-69(GPLD1/GPI)-27(-)-69(PLD)-14( Polyclonal)-4( Antibody,)-47( Cy7)-49( conjugated)]TJ
0 g
/TT1 1 Tf
0 Tw /Span<>> BDC
10.9457 0 0 10.9457 25.7344 311.6939 Tm
( )Tj
EMC
/Span<>> BDC
12.063 0 Td
( )Tj
EMC
/Span<>> BDC
12.125 0 Td
( )Tj
EMC
/Span<>> BDC
-24.187 -2.25 Td
( )Tj
EMC
/Span<>> BDC
12.063 0 Td
( )Tj
EMC
/Span<>> BDC
12.125 0 Td
( )Tj
EMC
/Span<>> BDC
-24.187 -2.25 Td
( )Tj
EMC
/Span<>> BDC
12.063 0 Td
( )Tj
EMC
/Span<>> BDC
12.125 0 Td
( )Tj
EMC
-0.04 Tw 7.5251 0 0 7.5251 27.1026 229.6015 Tm
[(For)-30( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
0 0.6 0.8 rg
0 Tw 6.841 0 0 6.841 185.8147 229.6015 Tm
(HERE)Tj
0 g
7.5251 0 0 7.5251 202.9173 229.6015 Tm
(.)Tj
ET
q
422.515 37.368 0.684 615.694 re
W n
q
/GS0 gs
0.6840973 0 0 -615.6936035 422.5147247 653.0618134 cm
/Im2 Do
Q
EMC
/Article <>BDC
EMC
/Article <>BDC
EMC
Q
endstream
endobj
23 0 obj
<>
endobj
24 0 obj
(?S>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L